These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15582406)

  • 1. Anti-coxsackievirus B3 activity of 2-amino-3-nitropyrazolo[1,5-a]pyrimidines and their analogs.
    Makarov VA; Riabova OB; Granik VG; Dahse HM; Stelzner A; Wutzler P; Schmidtke M
    Bioorg Med Chem Lett; 2005 Jan; 15(1):37-9. PubMed ID: 15582406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
    Chern JH; Shia KS; Hsu TA; Tai CL; Lee CC; Lee YC; Chang CS; Tseng SN; Shih SR
    Bioorg Med Chem Lett; 2004 May; 14(10):2519-25. PubMed ID: 15109643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anti-CVB 3 evaluation of substituted 5-nitro-2-phenoxybenzonitriles.
    Pürstinger G; De Palma AM; Zimmerhofer G; Huber S; Ladurner S; Neyts J
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5123-5. PubMed ID: 18710805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anti-HSV-1 evaluation of some pyrazoles and fused pyrazolopyrimidines.
    Rashad AE; Hegab MI; Abdel-Megeid RE; Fathalla N; Abdel-Megeid FM
    Eur J Med Chem; 2009 Aug; 44(8):3285-92. PubMed ID: 19285757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.
    Wang YX; Li YH; Li YH; Gao RM; Wang HQ; Liu YX; Gao LM; Lu QN; Jiang JD; Song DQ
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5787-90. PubMed ID: 21880491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives.
    Cheng J; Xie J; Luo X
    Bioorg Med Chem Lett; 2005 Jan; 15(2):267-9. PubMed ID: 15603937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR analysis of [(biphenyloxy)propyl]isoxazoles: agents against coxsackievirus B3.
    Muratov EN; Varlamova EV; Artemenko AG; Khristova T; Kuz'min VE; Makarov VA; Riabova OB; Wutzler P; Schmidtke M
    Future Med Chem; 2011 Jan; 3(1):15-27. PubMed ID: 21428823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of pyrazolo[4',3':5,6]pyrano[2,3-d]pyrimidine derivatives for antiviral evaluation.
    Shamroukh AH; Zaki ME; Morsy EM; Abdel-Motti FM; Abdel-Megeid FM
    Arch Pharm (Weinheim); 2007 May; 340(5):236-43. PubMed ID: 17464958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship of N-benzenesulfonyl matrinic acid derivatives as a novel class of coxsackievirus B3 inhibitors.
    Wang SG; Kong LY; Li YH; Cheng XY; Su F; Tang S; Bi CW; Jiang JD; Li YH; Song DQ
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3690-3. PubMed ID: 26112440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
    Schmidtke M; Wutzler P; Zieger R; Riabova OB; Makarov VA
    Antiviral Res; 2009 Jan; 81(1):56-63. PubMed ID: 18840470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses.
    Gudmundsson KS; Johns BA; Wang Z; Turner EM; Allen SH; Freeman GA; Boyd FL; Sexton CJ; Selleseth DW; Moniri KR; Creech KL
    Bioorg Med Chem; 2005 Sep; 13(18):5346-61. PubMed ID: 16039862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel substituted 9-norbornylpurines and their activities against RNA viruses.
    Sála M; Hřebabecký H; Leyssen P; Dejmek M; Dračínský M; De Palma AM; Neyts J; Nencka R
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1963-8. PubMed ID: 22310228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication.
    Makarov VA; Riabova OB; Granik VG; Wutzler P; Schmidtke M
    J Antimicrob Chemother; 2005 Apr; 55(4):483-8. PubMed ID: 15743897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
    Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
    J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of N-substituted sophocarpinic acid derivatives as coxsackievirus B3 inhibitors.
    Gao LM; Tang S; Wang YX; Gao RM; Zhang X; Peng ZG; Li JR; Jiang JD; Li YH; Song DQ
    ChemMedChem; 2013 Sep; 8(9):1545-53. PubMed ID: 23881611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of novel coxsackievirus B3 inhibitors.
    Sála M; De Palma AM; Hrebabecký H; Nencka R; Dracínský M; Leyssen P; Neyts J; Holý A
    Bioorg Med Chem; 2010 Jun; 18(12):4374-84. PubMed ID: 20576576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antiviral activity of 2,4-diamino-5-cyano-6-[2-(phosphonomethoxy)ethoxy]pyrimidine and related compounds.
    Hocková D; Holý A; Masojídková M; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Bioorg Med Chem; 2004 Jun; 12(12):3197-202. PubMed ID: 15158787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anti-tumor activities of novel pyrazolo[1,5-a]pyrimidines.
    Li J; Zhao YF; Zhao XL; Yuan XY; Gong P
    Arch Pharm (Weinheim); 2006 Nov; 339(11):593-7. PubMed ID: 17036367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones.
    Chern JH; Lee CC; Chang CS; Lee YC; Tai CL; Lin YT; Shia KS; Lee CY; Shih SR
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5051-6. PubMed ID: 15380197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of LNA-modified siRNAs against the highly structured 5' UTR of coxsackievirus B3.
    Dutkiewicz M; Grunert HP; Zeichhardt H; Lena SW; Wengel J; Kurreck J
    FEBS Lett; 2008 Sep; 582(20):3061-6. PubMed ID: 18691577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.